Published in Trends Endocrinol Metab on July 01, 2001
Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care (2011) 1.37
Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivo. PLoS One (2010) 1.06
Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes. Cardiovasc Res (2009) 0.95
Structural changes in the myocardium during diabetes-induced cardiomyopathy. Heart Fail Rev (2014) 0.89
Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice. PLoS One (2015) 0.82
Impact of protein energy wasting status on survival among Afro-Caribbean hemodialysis patients: a 3-year prospective study. Springerplus (2015) 0.82
Effect of rosiglitazone on progression of atherosclerosis: insights using 3D carotid cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2009) 0.82
Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta. Br J Pharmacol (2003) 0.81
Role of glomerular filtration rate in controlling blood pressure early in diabetes. Hypertension (2008) 0.79
Use of Metformin in Patients with Kidney and Cardiovascular Diseases. Cardiorenal Med (2011) 0.78
Characteristics of children and adolescents at onset of type 2 diabetes in a Tertiary Hospital in Bangladesh. Indian J Endocrinol Metab (2016) 0.75
(-)-Epicatechin-induced recovery of mitochondria from simulated diabetes: Potential role of endothelial nitric oxide synthase. Diab Vasc Dis Res (2016) 0.75
Symptom profiles of subsyndromal depression in disease clusters of diabetes, excess weight, and progressive cerebrovascular conditions: a promising new type of finding from a reliable innovation to estimate exhaustively specified multiple indicators-multiple causes (MIMIC) models. Diabetes Metab Syndr Obes (2016) 0.75
Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate. Res Pharm Sci (2013) 0.75
Relevance of plasma obestatin and early arteriosclerosis in patients with type 2 diabetes mellitus. J Diabetes Res (2013) 0.75
Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats. Inflammopharmacology (2012) 0.75
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA (1996) 4.03
Diabetes mellitus and hypertension. Hypertension (1992) 1.93
Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab (2001) 1.93
Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. N Engl J Med (1990) 1.80
Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med (1994) 1.74
Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol (1999) 1.61
Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab (2002) 1.47
Plasma norepinephrine responses to posture and isometric exercise increase with age in the absence of obesity. J Gerontol (1983) 1.46
Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol (1996) 1.41
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med (1990) 1.35
Antihypertensive therapy and the risk of type 2 diabetes mellitus. N Engl J Med (2000) 1.27
Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab (1976) 1.18
17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol (1994) 1.16
Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol (2000) 1.10
Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab (1982) 1.09
Cost effectiveness of 24-hour ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens (1994) 1.06
Downregulation of K(+) channel genes expression in type I diabetic cardiomyopathy. Biochem Biophys Res Commun (2001) 1.04
Enhanced 24-hour norepinephrine and renin secretion in young patients with essential hypertension: relation with the circadian pattern of arterial blood pressure. Am J Cardiol (1985) 1.03
Acute airway obstruction due to a benign cervical goiter. Otolaryngol Head Neck Surg (1987) 1.02
Ambulatory blood pressure monitoring in a nonacademic setting. Effects of age and sex. Am J Hypertens (1992) 0.99
Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension (1994) 0.99
Clinical review 91: Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab (1997) 0.98
Impairment of cardiopulmonary baroreflex after cardiac transplantation in humans. Circulation (1987) 0.97
Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO. Am J Physiol (1998) 0.97
Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med (1991) 0.95
Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest (1991) 0.95
Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol (1988) 0.95
Metabolism of exogenous human chorionic gonadotrophin in men. J Endocrinol (1979) 0.93
Hyperpigmentation, vitiligo, and Addison's disease. Cutis (1985) 0.93
Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts. Am J Pathol (1982) 0.90
Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J Pharmacol Exp Ther (1996) 0.89
Dopaminergic mediation of the natriuretic response to volume expansion. J Lab Clin Med (1985) 0.89
Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms. West J Med (1983) 0.89
Cardiovascular disease in the diabetic woman. J Clin Endocrinol Metab (1999) 0.89
Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women. Am J Hypertens (1995) 0.88
Circadian variation in plasma dopamine levels in man. J Endocrinol Invest (1984) 0.88
Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension (1982) 0.88
Influence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats. Hypertension (1999) 0.88
Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism. Evidence for dual defects in the gonadal axis. N Engl J Med (1985) 0.88
Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production. Diabetes (1997) 0.88
Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle. Endocrinology (1996) 0.87
Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology (1998) 0.87
Adrenal function following coronary bypass surgery. Am Heart J (1985) 0.87
Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2000) 0.86
Gender differences in vascular compliance in young, healthy subjects assessed by pulse contour analysis. J Clin Hypertens (Greenwich) (2001) 0.86
Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade. J Clin Endocrinol Metab (1981) 0.86
Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes. Diabetes (1999) 0.86
Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology (1996) 0.85
Altered dopaminergic modulation of sympathetic nervous system activity in idiopathic edema. J Endocrinol Invest (1984) 0.85
Comparison of metoclopramide with other dynamic tests of prolactin secretion. J Clin Endocrinol Metab (1976) 0.85
Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. Am J Med (1989) 0.85
Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension (1998) 0.85
Effects of high calcium intake on blood pressure and calcium metabolism in young SHR. Hypertension (1984) 0.85
Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol (Copenh) (1983) 0.85
Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes (1996) 0.84
Reductions in total and extracellular water associated with calcium-induced natriuresis and the antihypertensive effect of calcium in blacks. Am J Hypertens (1988) 0.84
An update on perioperative management of diabetes. Arch Intern Med (1999) 0.84
Hypertension in the elderly. Am J Med (1987) 0.84
Dissociation of 24-hour catecholamine levels from blood pressure in older men. Hypertension (1986) 0.84
Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis. Am J Kidney Dis (1993) 0.84
Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension. Hypertension (1982) 0.83
Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man. J Clin Endocrinol Metab (1980) 0.83
Growth hormone and prolactin secretion in Huntington's disease. Life Sci (1979) 0.83
Magnesium responsiveness to insulin and insulin-like growth factor I in erythrocytes from normotensive and hypertensive subjects. J Clin Endocrinol Metab (1998) 0.83
Dopaminergic regulation of natriuretic response to acute volume expansion in dogs. Clin Sci (Lond) (1985) 0.83
Dopaminergic modulation of renin release. Clin Exp Hypertens (1981) 0.83
Regulation of Na+,K(+)-ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens (1993) 0.82
Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. Life Sci (1997) 0.82
Relationship between urinary dopamine production and natriuresis after acute intravascular volume expansion with sodium chloride in dogs. Endocrinology (1984) 0.82
Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man. J Clin Endocrinol Metab (1977) 0.82
Plasma corticosteroid concentrations during spironolactone administration: evidence for adrenal biosynthetic blockade in man. J Clin Endocrinol Metab (1981) 0.81
Altered cation transport in non-insulin-dependent diabetic hypertension: effects of dietary calcium. J Hypertens Suppl (1988) 0.81
Impaired calcium metabolism associated with hypertension in Zucker obese rats. Metabolism (1990) 0.81
Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension. J Clin Endocrinol Metab (1981) 0.81
Role of PI3-kinase in isoproterenol and IGF-1 induced ecNOS activity. Biochem Biophys Res Commun (2001) 0.81
Myocardial norepinephrine, epinephrine and dopamine concentrations after cardiac autotransplantation in dogs. J Am Coll Cardiol (1986) 0.80
Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study. Am J Hypertens (1993) 0.80
"Effort thrombosis" of the subclavian vein associated with oral contraceptives. Ann Emerg Med (1981) 0.80
Reflex effects of prolonged cardiopulmonary baroreceptor unloading in humans. Am J Physiol (1988) 0.80
Managing geriatric hypertension: a brief review. Geriatrics (1985) 0.80
The effect of stressful diagnostic studies and surgery on anterior pituitary hormone release in man. Acta Endocrinol (Copenh) (1977) 0.80
Dopaminergic modulation of pressor and hormonal responses in essential hypertension. Hypertension (1982) 0.80
Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats. Endocrinology (1993) 0.80
Erythrocyte cation metabolism in salt-sensitive hypertensive blacks as affected by dietary sodium and calcium. Am J Hypertens (1988) 0.80
Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications. Am J Cardiol (1990) 0.80
Augmentation of the inotropic response to insulin in diabetic rat hearts. Life Sci (1999) 0.80
Influence of age on inotropic response to insulin and insulin-like growth factor I in spontaneously hypertensive rats: role of nitric oxide. Proc Soc Exp Biol Med (1999) 0.79
Hyperprolactinaemia in the spontaneously hypertensive rat. Acta Endocrinol (Copenh) (1979) 0.79
Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man. Life Sci (1982) 0.79
Evaluation and treatment of patients with prolactin-secreting pituitary tumors. Int J Gynaecol Obstet (1980) 0.79
Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab (1982) 0.79
How early should blood pressure control be achieved for optimal cardiovascular outcomes? J Hum Hypertens (2010) 0.79
Dietary calcium induces regression of left ventricular hypertrophy in hypertensive non-insulin-dependent diabetic blacks. Am J Hypertens (1990) 0.79
Dopaminergic Modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat. Proc Soc Exp Biol Med (1980) 0.79
Increased basal arterial smooth muscle glucose transport in the Zucker rat. Am J Hypertens (1995) 0.79
Effects of insulin and metformin on glucose metabolism in rat vascular smooth muscle. Metabolism (1999) 0.79
Reduced sodium-potassium dependent ATPase and its possible role in the development of hypertension in spontaneously hypertensive rats. Clin Exp Hypertens A (1983) 0.79
Effect of N3im-methyl-thyrotropin releasing hormone on the human pituitary-thyroid axis. J Clin Endocrinol Metab (1976) 0.79
Effect of prostaglandin inhibition on the prolactin, renin, and aldosterone responses to dopamine antagonism. Metabolism (1982) 0.78